Sponsored by Epicur Pharma® and Bova Group
*Please note: this recording is not approved for CE credits
The lecture highlights recent developments in the management of both squamous and glandular gastric disease. Recent publications will be reviewed and placed in the context of the existing knowledge base.
Appreciate the limitations of oral proton pump inhibitors in the management of gastric disease
Understand recent developments in the use of newer generation proton pump inhibitors
Learn how extended release injectable omeprazole is being used in the management of gastric disease
Have an understanding of the published evidence for a range of treatments for gastric disease
Following graduation from The University of Bristol in 2001, David worked in farm animal and equine practice in Somerset, UK before and completing an internship at Liphook Equine Hospital. A 3-year Horserace Betting Levy Board residency at The University of Glasgow and Liphook Equine Hospital enabled him to train as a specialist in equine internal medicine and to gain a masters by research into equine asthma and an RCVS certificate in equine medicine. David spent a number of years at Liphook Equine Hospital and had spells at The Royal Veterinary College and Charles Sturt University in Australia before moving to Rainbow Equine Hospital in Yorkshire where he became a director. David returned to his Westcountry roots in 2020 and now works as an independent equine medicine and therapeutics consultant. He is a Past President of the British Equine Veterinary Association, former chair of their health and medicines committee and sits on a number of equine industry advisory groups. David has an active research interest in equine endocrinology and gastroenterology and speaks regularly internationally.
We have a full library of webinars and other resources to help you continue learning about the topics important to you, your practice, and your patients!